Search results
Moderna’s next-gen COVID vaccine shows non-inferiority to its current shot
WHTC 1450 Holland· 5 days ago(Reuters) -Moderna said on Thursday its next-generation COVID-19 vaccine candidate met its main goal...
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 7 days agoPharmaceutical company Moderna has announced that a combination vaccine it has been developing...
Moderna says new-generation COVID vaccine more effective than Spikevax
Market Watch· 5 days agosaid Thursday a Phase 3 trial of its next-generation COVID-19 vaccine met its main goal and showed...
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 4 days agoModerna has announced that its Phase III clinical trial of the investigational next-generation Covid...
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
Clinical Trials Arena via Yahoo Finance· 5 days agoCovid-19 vaccine candidate. At this time, mRNA-1083 is poised to be the first Covid-19/influenza ...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-...
Morningstar· 5 days ago(NASDAQ:MRNA) today announced that its Phase 3 trial of mRNA-1283, an investigational next-generation COVID-19 vaccine, has met its primary ...
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
Zacks via Yahoo Finance· 6 days agoData from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination...
Moderna Just Gave Investors Another Reason to Buy the Stock
The Motley Fool via AOL· 1 day agoCOVID-19 vaccine and its investigational flu vaccine. mRNA-1083 knocked it out of the park in the...
Moderna says next-gen COVID shot effective in study
BioPharma Dive via Yahoo Finance· 5 days agoTrial data suggest the shot — an important component of an upcoming combination inoculation — has proven at least as effective, and in some cases...
Moderna's mRNA-1283 vaccine shows promise in Phase 3 trial By Investing.com
Investing.com· 4 days agoModerna , Inc. (NASDAQ:MRNA) has announced successful results from the Phase 3 trial of its...